Atopic Dermatitis Treatment Market, Global Outlook and Forecast 2022-2028

April 2022 | 60 pages | ID: A9C96039350EEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Atopic Dermatitis Treatment in Global, including the following market information:

Global Atopic Dermatitis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Atopic Dermatitis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Topical Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Atopic Dermatitis Treatment include Sanofi, Allergan, Novartis, Bristol Myers Squibb, Bayer, Meda Pharmaceuticals, Anacor Pharmaceutical, Pfizer and Astellas Pharma and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Atopic Dermatitis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Atopic Dermatitis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Atopic Dermatitis Treatment Market Segment Percentages, by Type, 2021 (%)

• Topical
• Oral
• Injectable

Global Atopic Dermatitis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Atopic Dermatitis Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

Global Atopic Dermatitis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Atopic Dermatitis Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Atopic Dermatitis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Atopic Dermatitis Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sanofi
• Allergan
• Novartis
• Bristol Myers Squibb
• Bayer
• Meda Pharmaceuticals
• Anacor Pharmaceutical
• Pfizer
• Astellas Pharma
• Regeneron Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Atopic Dermatitis Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Atopic Dermatitis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ATOPIC DERMATITIS TREATMENT OVERALL MARKET SIZE

2.1 Global Atopic Dermatitis Treatment Market Size: 2021 VS 2028
2.2 Global Atopic Dermatitis Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Atopic Dermatitis Treatment Players in Global Market
3.2 Top Global Atopic Dermatitis Treatment Companies Ranked by Revenue
3.3 Global Atopic Dermatitis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Atopic Dermatitis Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Atopic Dermatitis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Atopic Dermatitis Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Atopic Dermatitis Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Atopic Dermatitis Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Atopic Dermatitis Treatment Market Size Markets, 2021 & 2028
  4.1.2 Topical
  4.1.3 Oral
  4.1.4 Injectable
4.2 By Type - Global Atopic Dermatitis Treatment Revenue & Forecasts
  4.2.1 By Type - Global Atopic Dermatitis Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Atopic Dermatitis Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Atopic Dermatitis Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Atopic Dermatitis Treatment Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
  5.1.5 Others
5.2 By Application - Global Atopic Dermatitis Treatment Revenue & Forecasts
  5.2.1 By Application - Global Atopic Dermatitis Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Atopic Dermatitis Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Atopic Dermatitis Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Atopic Dermatitis Treatment Market Size, 2021 & 2028
6.2 By Region - Global Atopic Dermatitis Treatment Revenue & Forecasts
  6.2.1 By Region - Global Atopic Dermatitis Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Atopic Dermatitis Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Atopic Dermatitis Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Atopic Dermatitis Treatment Revenue, 2017-2028
  6.3.2 US Atopic Dermatitis Treatment Market Size, 2017-2028
  6.3.3 Canada Atopic Dermatitis Treatment Market Size, 2017-2028
  6.3.4 Mexico Atopic Dermatitis Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Atopic Dermatitis Treatment Revenue, 2017-2028
  6.4.2 Germany Atopic Dermatitis Treatment Market Size, 2017-2028
  6.4.3 France Atopic Dermatitis Treatment Market Size, 2017-2028
  6.4.4 U.K. Atopic Dermatitis Treatment Market Size, 2017-2028
  6.4.5 Italy Atopic Dermatitis Treatment Market Size, 2017-2028
  6.4.6 Russia Atopic Dermatitis Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Atopic Dermatitis Treatment Market Size, 2017-2028
  6.4.8 Benelux Atopic Dermatitis Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Atopic Dermatitis Treatment Revenue, 2017-2028
  6.5.2 China Atopic Dermatitis Treatment Market Size, 2017-2028
  6.5.3 Japan Atopic Dermatitis Treatment Market Size, 2017-2028
  6.5.4 South Korea Atopic Dermatitis Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Atopic Dermatitis Treatment Market Size, 2017-2028
  6.5.6 India Atopic Dermatitis Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Atopic Dermatitis Treatment Revenue, 2017-2028
  6.6.2 Brazil Atopic Dermatitis Treatment Market Size, 2017-2028
  6.6.3 Argentina Atopic Dermatitis Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Atopic Dermatitis Treatment Revenue, 2017-2028
  6.7.2 Turkey Atopic Dermatitis Treatment Market Size, 2017-2028
  6.7.3 Israel Atopic Dermatitis Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Atopic Dermatitis Treatment Market Size, 2017-2028
  6.7.5 UAE Atopic Dermatitis Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Sanofi
  7.1.1 Sanofi Corporate Summary
  7.1.2 Sanofi Business Overview
  7.1.3 Sanofi Atopic Dermatitis Treatment Major Product Offerings
  7.1.4 Sanofi Atopic Dermatitis Treatment Revenue in Global Market (2017-2022)
  7.1.5 Sanofi Key News
7.2 Allergan
  7.2.1 Allergan Corporate Summary
  7.2.2 Allergan Business Overview
  7.2.3 Allergan Atopic Dermatitis Treatment Major Product Offerings
  7.2.4 Allergan Atopic Dermatitis Treatment Revenue in Global Market (2017-2022)
  7.2.5 Allergan Key News
7.3 Novartis
  7.3.1 Novartis Corporate Summary
  7.3.2 Novartis Business Overview
  7.3.3 Novartis Atopic Dermatitis Treatment Major Product Offerings
  7.3.4 Novartis Atopic Dermatitis Treatment Revenue in Global Market (2017-2022)
  7.3.5 Novartis Key News
7.4 Bristol Myers Squibb
  7.4.1 Bristol Myers Squibb Corporate Summary
  7.4.2 Bristol Myers Squibb Business Overview
  7.4.3 Bristol Myers Squibb Atopic Dermatitis Treatment Major Product Offerings
  7.4.4 Bristol Myers Squibb Atopic Dermatitis Treatment Revenue in Global Market (2017-2022)
  7.4.5 Bristol Myers Squibb Key News
7.5 Bayer
  7.5.1 Bayer Corporate Summary
  7.5.2 Bayer Business Overview
  7.5.3 Bayer Atopic Dermatitis Treatment Major Product Offerings
  7.5.4 Bayer Atopic Dermatitis Treatment Revenue in Global Market (2017-2022)
  7.5.5 Bayer Key News
7.6 Meda Pharmaceuticals
  7.6.1 Meda Pharmaceuticals Corporate Summary
  7.6.2 Meda Pharmaceuticals Business Overview
  7.6.3 Meda Pharmaceuticals Atopic Dermatitis Treatment Major Product Offerings
  7.6.4 Meda Pharmaceuticals Atopic Dermatitis Treatment Revenue in Global Market (2017-2022)
  7.6.5 Meda Pharmaceuticals Key News
7.7 Anacor Pharmaceutical
  7.7.1 Anacor Pharmaceutical Corporate Summary
  7.7.2 Anacor Pharmaceutical Business Overview
  7.7.3 Anacor Pharmaceutical Atopic Dermatitis Treatment Major Product Offerings
  7.7.4 Anacor Pharmaceutical Atopic Dermatitis Treatment Revenue in Global Market (2017-2022)
  7.7.5 Anacor Pharmaceutical Key News
7.8 Pfizer
  7.8.1 Pfizer Corporate Summary
  7.8.2 Pfizer Business Overview
  7.8.3 Pfizer Atopic Dermatitis Treatment Major Product Offerings
  7.8.4 Pfizer Atopic Dermatitis Treatment Revenue in Global Market (2017-2022)
  7.8.5 Pfizer Key News
7.9 Astellas Pharma
  7.9.1 Astellas Pharma Corporate Summary
  7.9.2 Astellas Pharma Business Overview
  7.9.3 Astellas Pharma Atopic Dermatitis Treatment Major Product Offerings
  7.9.4 Astellas Pharma Atopic Dermatitis Treatment Revenue in Global Market (2017-2022)
  7.9.5 Astellas Pharma Key News
7.10 Regeneron Pharmaceuticals
  7.10.1 Regeneron Pharmaceuticals Corporate Summary
  7.10.2 Regeneron Pharmaceuticals Business Overview
  7.10.3 Regeneron Pharmaceuticals Atopic Dermatitis Treatment Major Product Offerings
  7.10.4 Regeneron Pharmaceuticals Atopic Dermatitis Treatment Revenue in Global Market (2017-2022)
  7.10.5 Regeneron Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Atopic Dermatitis Treatment Market Opportunities & Trends in Global Market
Table 2. Atopic Dermatitis Treatment Market Drivers in Global Market
Table 3. Atopic Dermatitis Treatment Market Restraints in Global Market
Table 4. Key Players of Atopic Dermatitis Treatment in Global Market
Table 5. Top Atopic Dermatitis Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Atopic Dermatitis Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Atopic Dermatitis Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Atopic Dermatitis Treatment Product Type
Table 9. List of Global Tier 1 Atopic Dermatitis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Atopic Dermatitis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Atopic Dermatitis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Atopic Dermatitis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Atopic Dermatitis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Atopic Dermatitis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Atopic Dermatitis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Atopic Dermatitis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Atopic Dermatitis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Atopic Dermatitis Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Atopic Dermatitis Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Atopic Dermatitis Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Atopic Dermatitis Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Atopic Dermatitis Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Atopic Dermatitis Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Atopic Dermatitis Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Atopic Dermatitis Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Atopic Dermatitis Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Atopic Dermatitis Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Atopic Dermatitis Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Atopic Dermatitis Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Sanofi Corporate Summary
Table 31. Sanofi Atopic Dermatitis Treatment Product Offerings
Table 32. Sanofi Atopic Dermatitis Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Allergan Corporate Summary
Table 34. Allergan Atopic Dermatitis Treatment Product Offerings
Table 35. Allergan Atopic Dermatitis Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Atopic Dermatitis Treatment Product Offerings
Table 38. Novartis Atopic Dermatitis Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Bristol Myers Squibb Corporate Summary
Table 40. Bristol Myers Squibb Atopic Dermatitis Treatment Product Offerings
Table 41. Bristol Myers Squibb Atopic Dermatitis Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Bayer Corporate Summary
Table 43. Bayer Atopic Dermatitis Treatment Product Offerings
Table 44. Bayer Atopic Dermatitis Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Meda Pharmaceuticals Corporate Summary
Table 46. Meda Pharmaceuticals Atopic Dermatitis Treatment Product Offerings
Table 47. Meda Pharmaceuticals Atopic Dermatitis Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Anacor Pharmaceutical Corporate Summary
Table 49. Anacor Pharmaceutical Atopic Dermatitis Treatment Product Offerings
Table 50. Anacor Pharmaceutical Atopic Dermatitis Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Pfizer Corporate Summary
Table 52. Pfizer Atopic Dermatitis Treatment Product Offerings
Table 53. Pfizer Atopic Dermatitis Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Astellas Pharma Corporate Summary
Table 55. Astellas Pharma Atopic Dermatitis Treatment Product Offerings
Table 56. Astellas Pharma Atopic Dermatitis Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Regeneron Pharmaceuticals Corporate Summary
Table 58. Regeneron Pharmaceuticals Atopic Dermatitis Treatment Product Offerings
Table 59. Regeneron Pharmaceuticals Atopic Dermatitis Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Atopic Dermatitis Treatment Segment by Type in 2021
Figure 2. Atopic Dermatitis Treatment Segment by Application in 2021
Figure 3. Global Atopic Dermatitis Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Atopic Dermatitis Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Atopic Dermatitis Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Atopic Dermatitis Treatment Revenue in 2021
Figure 8. By Type - Global Atopic Dermatitis Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Atopic Dermatitis Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Atopic Dermatitis Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Atopic Dermatitis Treatment Revenue Market Share, 2017-2028
Figure 12. US Atopic Dermatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Atopic Dermatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Atopic Dermatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Atopic Dermatitis Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Atopic Dermatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Atopic Dermatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Atopic Dermatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Atopic Dermatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Atopic Dermatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Atopic Dermatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Atopic Dermatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Atopic Dermatitis Treatment Revenue Market Share, 2017-2028
Figure 24. China Atopic Dermatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Atopic Dermatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Atopic Dermatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Atopic Dermatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Atopic Dermatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Atopic Dermatitis Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Atopic Dermatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Atopic Dermatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Atopic Dermatitis Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Atopic Dermatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Atopic Dermatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Atopic Dermatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Atopic Dermatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Sanofi Atopic Dermatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Allergan Atopic Dermatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Atopic Dermatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bristol Myers Squibb Atopic Dermatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bayer Atopic Dermatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Meda Pharmaceuticals Atopic Dermatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Anacor Pharmaceutical Atopic Dermatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Pfizer Atopic Dermatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Astellas Pharma Atopic Dermatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Regeneron Pharmaceuticals Atopic Dermatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)